Trophoblast Cell Surface Antigen 2 (TROP2) as a Predictive Bio-Marker for the Therapeutic Efficacy of Sacituzumab Govitecan in Adenocarcinoma of the Esophagus

By Sascha Hoppe, L. Meder, F. Gebauer, R. Ullrich, T. Zander, A. Hillmer, R. Buettner, P. Plum, J. Puppe, W. Malter and 1 more. 2022